Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Idorsia initiates registration study of lucerastat in adults with Fabry disease

May 16, 2018

Potential association of lonafarnib treatment with reduced mortality in children with HGPS

May 16, 2018

Pfenex reports topline results from study of PF-708 in osteoporosis

May 15, 2018

Soleno Therapeutics initiates phase III study of DCCR in Prader-Willi syndrome

May 15, 2018

Lipimetix sublicenses Apo E mimetic peptide platform to Anji

May 11, 2018

FDA advisory committee votes in favor of Waylivra for familial chylomicronemia syndrome

May 11, 2018

Phosphodiesterase PDE4 inhibitors patented byTakeda

May 11, 2018

LogicBio Therapeutics begins program for genome-editing therapy for methylmalonic acidemia

May 11, 2018

Lipocine receives FDA complete response letter for Tlando

May 10, 2018

Dare Bioscience enters agreement with Pear Tree Pharmaceuticals to secure rights to PT-101

May 9, 2018

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 14, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Clinical trial fraud ends with guilty pleas
BioWorld
In another real-life episode of “sponsor beware,” the owners of a clinical research facility pleaded guilty March 10 in U.S. district court to fraud charges...